Artículo

M1 macrophage polarization prevails in EBV infected children in an immuneregulatory environment

Moyano, Agustina Ayelén Icon; Ferressini Gerpe, Natalia Marina Icon; de Matteo, Elena Noemí Icon; Preciado, Maria Victoria Icon; Chabay, Paola Andrea Icon

Otros responsables

Fecha

2021-10-29

Editorial

American Society for Microbiology

Revista

Journal of Virology

Título del libro

Nombre del evento

Fecha del evento

Institución organizadora

ISSN

0022-538X

eISSN

ISBN

Idioma

Inglés

Tipo del evento

Clasificación temática

Resumen

Macrophages can be polarized toward a proinflammatory phenotype (M1) (CD68+) or to an anti-inflammatory one (M2) (CD163+). Polarization can be triggered by cytokines such as IFN-γ for M1, or IL-10 and TGF-β, for M2. In the context of pediatric EBV infection, little is known about macrophage polarization in EBV primary or persistent infection. When studying tonsils of patients undergoing primary infection (PI), healthy carrier (HC), reactivation (R) and not infected (NI), M1 profile prevailed in all infection status. However, an increase in M2 cells was observed in those patients with broader expression of latency antigens, in particular EBNA2. Tonsils from primary infected patients showed an increased IL-10 expression, whereas, unexpectedly, TGF-β expression correlated with M1 marker. Furthermore, an inverse correlation was demonstrated between CD68 and IFN-γ. Therefore, in the context of asymptomatic infection in children, M1 macrophage polarization prevails, even in the presence of IL-10 and TGF-b immunomodulatory cytokines, and it might be independent from lymphomagenesis process. Our finding indicates that macrophages may have a significant plasticity in response to different types of extrinsic stimuli, and further studies are required to investigate M1 polarization under anti-inflammatory stimuli.

Colecciones

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa